Chaselyn D. Ruffaner-Hanson

Chaselyn D. Ruffaner-Hanson

Auto-generated profile, based on publicly available information

Chaselyn D. Ruffaner-Hanson

Department of Neurosciences, School of Medicine University of New Mexico Albuquerque New Mexico USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Journal of Affective Disorders
Verified
Journal Article
Closed access
LWLu Wang
Lu Wang
YXYing Xue
Ying Xue
SCSong Cao
Song Cao
YXYuhong Xie
Yuhong Xie
CWChujun Wu
Chujun Wu
MTMi-Mi Tang
Mi-Mi Tang

8 April 2019 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
JSJoshua J Sanchez
Joshua J Sanchez
JSJacob E Sanchez
Jacob E Sanchez
SNShahani Noor
Shahani Noor
CRChaselyn D Ruffaner-Hanson
Chaselyn D Ruffaner-Hanson
SDSuzy Davies
Suzy Davies
EMErin D Milligan
Erin D Milligan
Recently, moderate prenatal alcohol exposure (PAE) was shown to be a risk factor for peripheral neuropathy following minor nerve injury. This effect coincides with elevated spinal cord astrocyte activation and ex vivo immune cell reactivity assessed by proinflammatory cytokine interleukin (IL) -1β protein expression. Additionally, the β2-integrin adhesion molecule, lymphocyte function-associated antigen-1 (LFA-1), a factor that influences the expression of the proinflammatory/anti-inflammatory cytokine network is upregulated. Here, we examine whether PAE increases the proinflammatory immune environment at specific anatomical sites critical in the pain pathway of chronic sciatic neuropathy; the damaged sciatic nerve (SCN), the dorsal root ganglia (DRG), and the spinal cord. Additionally, we examine whether inhibiting LFA-1 or IL-1β actions in the spinal cord (intrathecal; i.t., route) could alleviate chronic neuropathic pain and reduce spinal and DRG glial activation markers, proinflammatory cytokines, and elevate anti-inflammatory cytokines. Results show that blocking the actions of spinal LFA-1 using BIRT-377 abolishes allodynia in PAE rats with sciatic neuropathy (CCI) of a 10 or 28-day duration. This effect is observed (utilizing immunohistochemistry; IHC, with microscopy analysis and protein quantification) in parallel with reduced spinal glial activation, IL-1β and TNFα expression. DRG from PAE rats with neuropathy reveal significant increases in satellite glial activation and IL-1β, while IL-10 immunoreactivity is reduced by half in PAE rats under basal and neuropathic conditions. Further, blocking spinal IL-1β with i.t. IL-1RA transiently abolishes allodynia in PAE rats, suggesting that IL-1β is in part, necessary for the susceptibility of adult-onset peripheral neuropathy caused by PAE. Chemokine mRNA analyses from SCN, DRG and spinal cord reveal that increased CCL2 occurs following CCI injury regardless of PAE and BIRT-377 treatment. These data demonstrate that PAE creates dysregulated proinflammatory IL-1β and TNFα /IL-10 responses to minor injury in the sciatic-DRG-spinal pain pathway. PAE creates a risk for developing peripheral neuropathies, and LFA-1 may be a novel therapeutic target for controlling dysregulated neuroimmune actions as a consequence of PAE.

5 November 2023 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
SNShahani Noor
Shahani Noor
MSMelody S. Sun
Melody S. Sun
APAndrea A. Pasmay
Andrea A. Pasmay
APAriana N. Pritha
Ariana N. Pritha
CRChaselyn D. Ruffaner‐Hanson
Chaselyn D. Ruffaner‐Hanson
EMErin D. Milligan
Erin D. Milligan